Press Release Archive

11.30.2018

Pfizer Reaches a Global Agreement with AbbVie

11.27.2018

Pfizer Receives Six Months Pediatric Exclusivity for LYRICA® (pregabalin)

11.26.2018

Pfizer Inc. Issues A Voluntary Nationwide Consumer Level Recall Of Six Lots Of ThermaCare® HeatWraps Due To Leaking Wraps with the Potential For Skin Injuries

11.21.2018

U.S. FDA Approves DAURISMO™ (glasdegib) for Adult Patients with Newly-Diagnosed Acute Myeloid Leukemia (AML) for Whom Intensive Chemotherapy is Not an Option

11.19.2018

Merck KGaA, Darmstadt, Germany, and Pfizer Provide Update on Avelumab in Platinum-Resistant/Refractory Ovarian Cancer

11.16.2018

Pfizer Provides Transparency On Drug Prices In The U.S. 90 Percent Of Company’s Prices Will Remain Unchanged

11.11.2018

Real-World Evidence on Patients Aged 80 and Older Presented From ARISTOPHANES, the Largest Real-World Data Study Evaluating Oral Anticoagulants Among Patients with Non-Valvular Atrial Fibrillation

11.09.2018

Data From Phase 2 PALLET Study of IBRANCE® (palbociclib)in Early Breast Cancer to be Presented at San Antonio Breast Cancer Symposium

11.02.2018

U.S. FDA Approves LORBRENA® (lorlatinib) for Previously-Treated ALK-Positive Metastatic NSCLC

10.30.2018

PFIZER REPORTS THIRD-QUARTER 2018 RESULTS

10.28.2018

Pfizer Announces Clinical Development Agreement with Novartis to Advance the Treatment of NASH

10.25.2018

CANCER THERAPEUTICS CRC SIGNS AGREEMENT TO ENABLE PFIZER TO DEVELOP NOVEL CANCER DRUGS